| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI algorithms can analyze medical images (like X-rays, CT scans, and MRIs) to detect subtle patterns and anomalies that might be missed by human eyes |
AI in the medical imaging industry is to improve diagnostic accuracy and patient outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI algorithms can analyze medical images and highlight areas of concern, essentially providing a "second set of eyes" for radiologists |
AI can help to improve diagnostic accuracy and reduce the chances of errors, ultimately leading to better patient care |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
It's about having a basic understanding of what AI is, how it works, and its potential impact on society. |
article, AI literacy refers to understanding and knowledge of AI technology. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The factor NOT listed as influencing the acceptability of AI among healthcare professionals is the color of the AI machines. The other options, trust, workflow integration, system understanding, and technology receptiveness, are all relevant |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
|
Influences AI's Diagnostic Accuracy: Diagnostic accuracy is primarily determined by the AI's technical capabilities and the data it's trained on, not social influence. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
While the other options might be valid concerns to some extent, the fear of job displacement is the most widely discussed and significant perceived threat. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Creating AI takes into account human needs. |
This approach focuses on creating AI tools that are easy to use. and integrates seamlessly into existing workflows. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
encompasses things like how well it integrates with existing systems, whether it's easy |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Only relevant in legal contexts |
|
The use of Al in medicine must be based on legal considerations. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Educational articles must primarily refer to the reader's expertise. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The main purpose of using human embryonic stem cells in the treatment of Parkinson's disease is to replace lost dopamine neurons. |
Parkinson's disease is a neurological disease caused by the degeneration of nerve cells that produce dopamine. which is an important neurotransmitter for controlling movement The use of embryonic stem cells has the potential to generate new dopaminergic neurons. to replace lost cells and help relieve symptoms of disease |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Monkeys are often chosen for advanced preclinical neurotherapeutic testing because of their similarity to humans, such as STEM-PD. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
This is an early stage trial to evaluate the safety and appropriate dosage for treating Parkinson's disease. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under GMP-Compliant Conditions. This means it adheres to Good Manufacturing |
Good Manufacturing Practices, a set of regulations and guidelines ensuring quality, safety, and efficacy in the production of pharmaceutical products. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells increased cognitive impairments. |
|
The key finding noted in the efficacy study of STEM-PD in rats was that transplanted cells reversed motor deficits in rats. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|